2-(1H-IMIDAZOL-1-YL)-N-(2-(2-METHOXYETHOXY)-5-PYRIMIDINYL)-6-(TRIFLUOROMETHYL)-4-PYRIMIDINECARBOXAMIDE
UNII 8TE669PH9F
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-(1h-imidazol-1-yl)-n-(2-(2-methoxyethoxy)-5-pyrimidinyl)-6-(trifluoromethyl)-4-pyrimidinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8TE669PH9F.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2857868-82-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H14F3N7O3 HETNKTFSCIEHQT-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-(1h-imidazol-1-yl)-n-(2-(2-methoxyethoxy)-5-pyrimidinyl)-6-(trifluoromethyl)-4-pyrimidinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.